- Home
- DCTH vs EAD Comparison
DCTH vs EAD Comparison
Compare DCTH & EAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- EAD
- Stock Information
- Founded
- DCTH 1988
- EAD 2003
- Country
- DCTH United States
- EAD United States
- Employees
- DCTH N/A
- EAD N/A
- Industry
- DCTH Medical/Dental Instruments
- EAD Finance/Investors Services
- Sector
- DCTH Health Care
- EAD Finance
- Exchange
- DCTH Nasdaq
- EAD Nasdaq
- Market Cap
- DCTH 388.3M
- EAD 419.0M
- IPO Year
- DCTH N/A
- EAD N/A
- Fundamental
- Price
- DCTH $10.67
- EAD $7.09
- Analyst Decision
- DCTH Strong Buy
- EAD
- Analyst Count
- DCTH 4
- EAD 0
- Target Price
- DCTH $24.50
- EAD N/A
- AVG Volume (30 Days)
- DCTH 485.5K
- EAD 178.9K
- Earning Date
- DCTH 11-07-2025
- EAD 01-01-0001
- Dividend Yield
- DCTH N/A
- EAD 8.91%
- EPS Growth
- DCTH N/A
- EAD N/A
- EPS
- DCTH 0.06
- EAD N/A
- Revenue
- DCTH $70,240,000.00
- EAD N/A
- Revenue This Year
- DCTH $159.22
- EAD N/A
- Revenue Next Year
- DCTH $41.22
- EAD N/A
- P/E Ratio
- DCTH $193.75
- EAD N/A
- Revenue Growth
- DCTH 491.35
- EAD N/A
- 52 Week Low
- DCTH $8.08
- EAD $5.69
- 52 Week High
- DCTH $18.23
- EAD $6.81
- Technical
- Relative Strength Index (RSI)
- DCTH 43.30
- EAD 51.84
- Support Level
- DCTH $10.60
- EAD $7.07
- Resistance Level
- DCTH $11.38
- EAD $7.15
- Average True Range (ATR)
- DCTH 0.44
- EAD 0.03
- MACD
- DCTH 0.01
- EAD -0.00
- Stochastic Oscillator
- DCTH 5.26
- EAD 36.67
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About EAD Allspring Income Opportunities Fund
Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.